Explore the Washington Court's decision on health insurer coverage for weight loss medications, implications for patients, and the ongoing legal debate.

The Trump administration proposes a Medicare and Medicaid pilot program for covering GLP-1 weight loss drugs, marking a key shift in healthcare policy and potential budget impacts.